EKSO
Ekso Bionics Holdings, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$15.90
−9.86%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 11.6M | 12.8M | 17.9M | 18.3M | 12.9M |
| Cost of Revenue | 5.5M | 6.0M | 8.4M | 9.2M | 6.7M |
| Gross Profit | 6.1M | 6.8M | 9.5M | 9.1M | 6.2M |
| Operating Expenses | |||||
| R&D Expense | 2.6M | 3.0M | 3.9M | 5.0M | 3.6M |
| SG&A Expense | 19.0M | 17.1M | 16.1M | 19.2M | 18.1M |
| General & Admin Expense | 11.5M | 10.0M | 8.8M | 10.7M | 11.0M |
| Selling & Marketing Expense | 7.5M | 7.2M | 7.3M | 8.5M | 7.2M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 21.6M | 20.2M | 20.0M | 24.2M | 21.8M |
| Cost and Expenses | 27.1M | 26.1M | 28.4M | 33.4M | 28.5M |
| Operating Income (EBIT) | (15.5M) | (13.3M) | (10.5M) | (15.1M) | (15.6M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 690.0K | 309.0K | 269.0K | 302.0K | 156.0K |
| Net Interest Income | (690.0K) | (309.0K) | (269.0K) | (302.0K) | (156.0K) |
| Other Non-Op Income/Expense | (185.0K) | 1.6M | (870.0K) | (86.0K) | 476.0K |
| Non-Operating Income (excl Interest) | (505.0K) | (1.9M) | 601.0K | (216.0K) | (632.0K) |
| EBT (Pre-Tax Income) | (15.7M) | (11.7M) | (11.3M) | (15.2M) | (15.1M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (15.7M) | (11.7M) | (11.3M) | (15.2M) | (15.1M) |
| Earnings from Cont. Ops | (15.7M) | (11.7M) | (11.3M) | (15.2M) | (15.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (16.1M) | (11.7M) | (11.3M) | (15.2M) | (15.1M) |
| Per Share | |||||
| Basic EPS | ($5.39) | ($4.91) | ($8.43) | ($16.44) | ($17.45) |
| Diluted EPS | ($5.39) | ($4.91) | ($8.43) | ($16.44) | ($17.45) |
| Revenue Per Share | $3.25 | $5.28 | $13.34 | $19.77 | $14.94 |
| Shares | |||||
| Basic Shares Outstanding | 3.6M | 2.4M | 1.3M | 924466 | 864133 |
| Diluted Shares Outstanding | 3.6M | 2.4M | 1.3M | 924466 | 864133 |
| Profitability Metrics | |||||
| EBITDA | (13.3M) | (9.8M) | (9.5M) | (13.2M) | (14.0M) |
| D&A | 1.6M | 1.6M | 1.6M | 1.7M | 887.0K |
| EBIT | (15.0M) | (11.4M) | (11.1M) | (14.9M) | (14.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026